Stetson Van Matre

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Medical Student

University of Central Arkansas UAMS primary

Also affiliated: Arkansas Children's Research Institute (2026)

2 h-index 7 pubs 13 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Stetson Van Matre's research has focused on the intersection of materials science and cancer therapy, specifically investigating the use of gold nanoparticles to enhance radiosensitivity in pancreatic cancer. His work includes studies on targeting amyloid fibrils with gold nanoparticles to rescue pancreatic islet beta-cells and restore insulin homeostasis. Van Matre has also explored the inhibition of Cyclin-dependent kinase 1 as a strategy to radiosensitize pancreatic cancer. His publications also extend to case reports on dermatological conditions, such as topical sirolimus therapy for pyogenic granulomas, and investigations into the immunosuppressive microenvironment of arteriovenous malformations characterized by M2 macrophage polarization. Van Matre's scholarly output includes six publications with 13 citations and an h-index of 2. He has collaborated with researchers including Adam R. Wolfe, Oscar Zuniga, and Henrique Rodrigues at the University of Arkansas for Medical Sciences.

Metrics

h-index: 2
Publications: 7
Citations: 13

Positions

Medical Student publications 2023–2026

University of Arkansas for Medical Sciences College of Medicine ORCID

Selected Publications

Topical Sirolimus Therapy for Agminated Pyogenic Granulomas: A Two‐Case Report (2026)

Pediatric Dermatology DOI OpenAlex
M2 Macrophage Polarization Characterizes an Immunosuppressive Microenvironment in Extracranial Arteriovenous Malformations (2026)

Biomedicines DOI OpenAlex
Amyloid Targeting-Gold Nanoparticles-Assisted X-ray Therapy Rescues Islet β-Cells from Amyloid Fibrils and Restores Insulin Homeostasis (2025)

ACS Nano 7 citations DOI OpenAlex
Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1 (2024)

Cancer Research DOI OpenAlex
Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1 (2024)

Radiotherapy and Oncology 6 citations DOI OpenAlex
Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer (2023)

Cancer Research DOI OpenAlex